Josh Blacher, Chief Business Officer at InMed Pharmaceuticals, recently spoke to us about the groundbreaking researching his company is doing using biosynthesis to create cannabinoid-based pharmaceutical products.
Jeff Zorn, the CEO and Owner of Cannabis Training University, discusses the different courses they offer, what sets them apart from other cannabis training facilities, and more.
Cannabis Science and Technology’s editor-in-chief will be hosting a special screening of the documentary Weed the People on January 8, 2019 at 7:30 p.m.
South Korea has become the first country in East Asia to legalize medical cannabis.
November 20, 2018 marked the first East Coast sales for recreational cannabis in the United States.
We recently spoke with Eric Furman, PhD, a partner at Knobbe Martens a leading intellectual property law firm with an expansive presence in the biotech and pharmaceutical fields and deep experience in intellectual property issues relating to the cannabis industry. Here, Furman provides some insight on what cases are currently on-going and what we might expect in the future as the cannabis industry continues to expand.
Dr. Les Brown, Managing Director of AECS-QuikPrep Ltd., recently spoke to us about the benefits of countercurrent chromatography (CCC) compared to other methods as well as the work his company has been doing to advance the technique for their clients in the cannabis industry.
Cannabis Science and Technology is pleased to announce the launch of its editorial advisory board.
The University of Connecticut (UConn, Storrs, Connecticut) announced plans to offer a class on cannabis horticulture through the Department of Plant Science and Landscape Architecture.
According to a recent New York Times article, doctors in the United Kingdom will be allowed to write prescriptions for medical cannabis as of November 1, 2018.